NFKB1 and chronic obstructive pulmonary disease: Our study has limitations: while we establish correlations between NETs components, disease severity, and NF-kB-dependent cytokines levels in BALF of patients with COPD adhering to standard LAMA or ICS + LABA therapies, we lack information on individual pharmacological regimens that might impact MPO and NE levels.